Leiner pleads guilty

Executive Summary

Leiner Health Products formally pleads guilty to knowingly shipping 1,275 drug batches that failed stability tests, and will pay a $10 million fine to resolve allegations its Fort Mill, S.C., plant violated good manufacturing practices, according to court documents filed earlier this month. In exchange, the Department of Justice will not prosecute Leiner. The deal will not impact NBTY's plans to acquire the company for $371 million, NBTY CEO Harvey Kamil said (1"The Tan Sheet" June 16, 2008, p. 3)...